Literature DB >> 32148138

Inequity in palliative care service full utilisation among patients with advanced cancer: a retrospective Cohort study.

Daniela D'Angelo1, Marco Di Nitto2, Diana Giannarelli3, Ileana Croci4, Roberto Latina5, Anna Marchetti6, Caterina Magnani7, Chiara Mastroianni7, Michela Piredda6, Marco Artico8, Maria Grazia De Marinis6.   

Abstract

Background: Advanced cancer patients often die in hospital after receiving needless, aggressive treatment. Although palliative care improves symptom management, barriers to accessing palliative care services affect its utilisation, and such disparities challenge the equitable provision of palliative care. This study aimed to identify which factors are associated with inequitable palliative care service utilisation among advanced cancer patients by applying the Andersen Behavioural Model of Health Services Use.Material and methods: This was a retrospective cohort study using administrative healthcare data. A total of 13,656 patients residing in the Lazio region of Italy, who died of an advanced cancer-related cause-either in hospital or in a specialised palliative care facility-during the period of 2012-2016 were included in the study. Potential predictors of specialised palliative service utilisation were explored by grouping the following factors: predisposing factors (i.e., individuals' characteristics), enabling factors (i.e., systemic/structural factors) and need factors (i.e., type/severity of illness).
Results: The logistic hierarchical regression showed that older patients (odds ratio [OR] = 1.45; <0.0001) of Caucasian ethnicity (OR = 4.17; 0.02), with a solid tumour (OR = 1.87; <0.0001) and with a longer survival time (OR = 2.09; <0.0001) were more likely to be enrolled in a palliative care service. Patients who lived farther from a specialised palliative care facility (OR = 0.13; <0.0001) and in an urban area (OR = 0.58; <0.0001) were less likely to be enrolled.
Conclusion: This study found that socio-demographic (age, ethnicity), clinical (type of tumour, survival time) and organisational (area of residence, distance from service) factors affect the utilisation of specialised palliative care services. The fact that service utilisation is not only a function of patients' needs but also of other aspects demonstrates the presence of inequity in access to palliative care among advanced cancer patients.

Entities:  

Mesh:

Year:  2020        PMID: 32148138     DOI: 10.1080/0284186X.2020.1736335

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  5 in total

1.  Physician-Patient Relationship, Assisted Suicide and the Italian Constitutional Court.

Authors:  E Turillazzi; A Maiese; P Frati; M Scopetti; M Di Paolo
Journal:  J Bioeth Inq       Date:  2021-10-21       Impact factor: 1.352

2.  Factors influencing place of death and disenrollment among patients receiving specialist palliative care.

Authors:  Marco Di Nitto; Marco Artico; Michela Piredda; Maddalena De Maria; Caterina Magnani; Anna Marchetti; Chiara Mastroianni; Roberto Latina; Maria Grazia De Marinis; Daniela D'Angelo
Journal:  Acta Biomed       Date:  2022-05-12

3.  Preferred place of death and end-of-life care for adult cancer patients in Iran: A cross-sectional study.

Authors:  Armin Fereidouni; Mahmood Salesi; Maryam Rassouli; Fariba Hosseinzadegan; Mohammad Javid; Maryam Karami; Maryam Elahikhah; Salman Barasteh
Journal:  Front Oncol       Date:  2022-08-03       Impact factor: 5.738

4.  Acute healthcare utilization in end-of-life among Swedish brain tumor patients - a population based register study.

Authors:  Magnus Lindskog; Torbjörn Schultz; Peter Strang
Journal:  BMC Palliat Care       Date:  2022-07-23       Impact factor: 3.113

5.  Palliative care needs of the cancer patients receiving active therapy.

Authors:  Gülcan Bağçivan; Memnun Seven; Şeyma İnciser Paşalak; Ezgi Bilmiç; Yasemin Aydın; Gözde Öz; Fatih Selçukbiricik
Journal:  Support Care Cancer       Date:  2021-08-09       Impact factor: 3.603

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.